C07K 14/162
Env
Official title: {env, e.g. gp160, gp110/120, gp41, V3, peptid T, CD4-Binding site}
C07K14/162 (Env) appears on 100 US grants and 143 published applications in this corpus.
Search patents in C07K- Granted patents
- 100
- Published applications
- 143
- Assignees
- 95
- Inventors
- 276
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 5 |
| 2012 | 1 | 1 |
| 2013 | 1 | 5 |
| 2014 | 2 | 4 |
| 2015 | 2 | 6 |
| 2016 | 3 | 16 |
| 2017 | 7 | 2 |
| 2018 | 15 | 9 |
| 2019 | 8 | 18 |
| 2020 | 7 | 13 |
| 2021 | 13 | 21 |
| 2022 | 9 | 8 |
| 2023 | 8 | 9 |
| 2024 | 10 | 10 |
| 2025 | 5 | 4 |
| 2026 | 6 | 6 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Rapid elicitation of broadly neutralizing bovine antibodies to HIV Env25 Aug 2026US 12,715,907 B2International AIDS Vaccine Initiative
- Immunogenic trimers2 Jun 2026US 12,642,848 B2International AIDS Vaccine Initiative
- Immunogenic trimers21 Apr 2026US 12,605,441 B2International AIDS Vaccine Initiative
- Self-assembling insect ferritin nanoparticles21 Apr 2026US 12,606,596 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Ferritin nanoparticle displaying an HIV trimer10 Mar 2026US 12,570,701 B2International AIDS Vaccine Initiative
- Immunogenic trimers17 Sep 2026US 2026/0273042 A1International AIDS Vaccine Initiative
- Recombinant hiv env polypeptides and their use27 Aug 2026US 2026/0250331 A1International AIDS Vaccine Initiative
- Broadly neutralizing antibody-templated divalent immunogen vaccines16 Jul 2026US 2026/0201018 A1University of Hawaii
- Non-Signaling HIV Fusion Inhibitors And Methods Of Use Thereof18 Jun 2026US 2026/0167978 A1The Trustees of the University of Pennsylvania
- Stem cell based delivery of tumor-specific retroviral vectors21 May 2026US 2026/0139275 A1Abintus Bio, Inc.
Most cited
By later US patents
- Recombinant HCMV and RHCMV vectors and uses thereof20US 9,249,427 B2Oregon Health & Science University · 2016
- Recombinant HCMV and RHCMV vectors and uses thereof13US 9,982,241 B2Oregon Health & Science University · 2018
- Method of evaluating a patient antibody response to envelope proteins of a virus12US 7,247,439 B1Monogram Biosciences, Inc. · 2007
- Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens7US 10,961,283 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2021
- Stabilized mosaic human immunodeficiency virus type 1 (HIV-1) GP140 envelope (ENV) trimers7US 9,932,370 B2Beth Israel Deaconess Medical Center, Inc. · 2018